Merck KGaA (MKGAF)
OTCMKTS
· Delayed Price · Currency is USD
136.50
-8.34 (-5.75%)
Dec 4, 2025, 3:52 PM EST
Merck KGaA Revenue
Merck KGaA had revenue of 5.32B EUR in the quarter ending September 30, 2025, with 0.99% growth. This brings the company's revenue in the last twelve months to 21.27B, up 1.47% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.27B EUR
Revenue Growth
+1.47%
P/S Ratio
2.45
Revenue / Employee
360.40K EUR
Employees
59,020
Market Cap
61.02B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Mid-Atlantic Home Health Network | 27.00M |
Merck KGaA News
- 1 day ago - Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case - WSJ
- 2 days ago - Dr. Rasha Kelej of Merck Foundation Meets Nigeria First Lady at the Merck Foundation Africa Asia Luminary 2025 - Business Upturn
- 11 days ago - Merck Foundation Observes the ‘Day for Elimination of Violence Against Women 2025’ Through Their More Than a Mother Campaign and Educating Linda Program - Business Upturn
- 14 days ago - Equinix Hosts Merck KGaA's HPC at its Data Center in Germany - Nasdaq
- 15 days ago - Valo Health Partners with Merck KGaA in $3B AI Drug Discovery Deal - GuruFocus
- 16 days ago - Merck KGaA inks $3B deal to discover Parkinson’s drugs using AI - Seeking Alpha
- 16 days ago - Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters
- 16 days ago - Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson's Disease and Related Disorders - Business Wire